The opioid antagonist, MR2266, specifically decreases saline intake in the mouse.
The effects of the opioid antagonist, Mr2266 [(-)-(1R,5R,9R)-5,9-diethyl-2-(3-furyl-methyl)-2'-hydroxy-6,7-benzomo rph an] on the intake of water and saline (0.9%) were investigated in the mouse, deprived of water for 24 hr. In an attempt to evaluate motor functions, the behavior after treatment with Mr2266 was also examined by using multi-dimensional behavioral analyses. Although smaller doses (1.0, 3.0 and 10.0 mg/kg) of Mr2266 failed to affect significantly the intake of water, a larger dose (30.0 mg/kg) elicited a significant attenuation in the intake of water. During a 30 min observation, Mr2266 (30.0 mg/kg) depressed markedly linear locomotion, while other behavioral responses, such as rearing and grooming, remained unchanged. In contrast, 1.0-30.0 mg/kg doses of the drug produced a significant reduction in the intake of saline. The drug Mr2266 had no significant effects on the latency to start drinking at any doses tested. These results suggest that Mr2266 specifically blocks the intake of saline of the mouse through the mediation of opioid systems.
Ukai
M
M
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan.
Nakayama
S
S
Kameyama
T
T
D000818:Animals; D001575:Benzomorphans / Q000494:pharmacology*; D004326:Drinking / Q000187:drug effects*; D004566:Electrodes; D008124:Locomotion / Q000187:drug effects; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008838:Microcomputers; D009019:Morphinans / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D012965:Sodium Chloride
D001575:Benzomorphans; D009019:Morphinans; D009292:Narcotic Antagonists; D012965:Sodium Chloride; C027247:MR 2266